Interestingly, p15INK4b or p16INK4a seem unaffected at any stage of CML (140), whereas hypermethylation of p15INK4b and p16INK4a is a common event in multiple myeloma (MM) (141). Here, CDKN2B is linked to chronic myelogenous leukemia, BCR-ABL1 positive.